These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA, Fallico N, Mazzocchi M, Scuderi N. Am J Clin Dermatol; 2011 Dec 01; 12(6):377-88. PubMed ID: 21877763 [Abstract] [Full Text] [Related]
5. Botulinum toxin products overview. Carruthers A, Carruthers J. Skin Therapy Lett; 2008 Dec 01; 13(6):1-4. PubMed ID: 18806905 [Abstract] [Full Text] [Related]
12. Compositional differences among commercially available botulinum toxin type A. Bakshi E, Hartstein ME. Curr Opin Ophthalmol; 2011 Sep 01; 22(5):407-12. PubMed ID: 21825992 [Abstract] [Full Text] [Related]
13. Botulinum toxin in facial rejuvenation: an update. Carruthers J, Carruthers A. Dermatol Clin; 2009 Oct 01; 27(4):417-25, v. PubMed ID: 19850191 [Abstract] [Full Text] [Related]
14. Commentary: Botulinum toxin in clinical medicine: part II. Benedetto AV. Clin Dermatol; 2004 Oct 01; 22(1):1-2. PubMed ID: 15158537 [No Abstract] [Full Text] [Related]
15. Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review. Sattler G. J Drugs Dermatol; 2010 Sep 01; 9(9):1065-71. PubMed ID: 20865836 [Abstract] [Full Text] [Related]